Canada Life’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.9M Buy
199,660
+110,231
+123% +$18.8M 0.06% 251
2025
Q4
$12.6M Buy
89,429
+33,874
+61% +$3.84M 0.02% 461
2025
Q3
$4.83M Buy
55,555
+27,802
+100% +$2.14M 0.01% 837
2025
Q2
$1.74M Sell
27,753
-13,664
-33% -$808K ﹤0.01% 1242
2025
Q1
$2.99M Buy
41,417
+265
+0.6% +$21.6K 0.01% 1021
2024
Q4
$3.54M Sell
41,152
-55,020
-57% -$5.48M 0.01% 1009
2024
Q3
$9.12M Sell
96,172
-2,076
-2% -$184K 0.02% 614
2024
Q2
$9.4M Buy
98,248
+24,369
+33% +$2.9M 0.02% 573
2024
Q1
$9.74M Sell
73,879
-57,009
-44% -$7.02M 0.02% 572
2023
Q4
$18.8M Buy
130,888
+6,743
+5% +$926K 0.04% 390
2023
Q3
$21.1M Sell
124,145
-1,758
-1% -$350K 0.05% 343
2023
Q2
$28.2M Sell
125,903
-1,900
-1% -$389K 0.07% 291
2023
Q1
$28.3M Sell
127,803
-4,620
-3% -$1.14M 0.07% 276
2022
Q4
$28.8M Buy
132,423
+25,315
+24% +$6.75M 0.08% 270
2022
Q3
$28.3M Buy
107,108
+4,234
+4% +$1.08M 0.08% 244
2022
Q2
$21.5M Sell
102,874
-50,754
-33% -$11.3M 0.06% 329
2022
Q1
$35.4M Buy
153,628
+25,416
+20% +$5.37M 0.07% 274
2021
Q4
$29.9M Buy
128,212
+5,439
+4% +$1.35M 0.06% 319
2021
Q3
$27.1M Buy
122,773
+14,331
+13% +$3.06M 0.06% 321
2021
Q2
$18.3M Sell
108,442
-18,311
-14% -$2.96M 0.04% 424
2021
Q1
$18.5M Buy
126,753
+31,483
+33% +$5.05M 0.04% 404
2020
Q4
$14M Buy
95,270
+34,302
+56% +$4.07M 0.03% 511
2020
Q3
$5.44M Buy
60,968
+3,039
+5% +$269K 0.01% 687
2020
Q2
$4.46M Buy
57,929
+991
+2% +$67.3K 0.01% 724
2020
Q1
$3.22M Sell
56,938
-2,213
-4% -$170K 0.01% 764
2019
Q4
$4.29M Sell
59,151
-6,045
-9% -$404K 0.01% 762
2019
Q3
$4.54M Sell
65,196
-26
-0% -$1.77K 0.01% 697
2019
Q2
$4.59M Buy
+65,222
New +$4.81M 0.01% 763
2019
Q1
Sell
-81,221
Closed -$6.01M 2578
2018
Q4
$6.01M Sell
81,221
-3,147
-4% -$297K 0.02% 601
2018
Q3
$8.42M Sell
84,368
-8,830
-9% -$855K 0.02% 553
2018
Q2
$8.8M Sell
93,198
-27,570
-23% -$2.65M 0.02% 567
2018
Q1
$11.2M Buy
120,768
+17,529
+17% +$1.93M 0.03% 489
2017
Q4
$13.2M Sell
103,239
-4,602
-4% -$624K 0.03% 441
2017
Q3
$14.4M Sell
107,841
-824
-0.8% -$98K 0.04% 419
2017
Q2
$11.5M Buy
108,665
+30,232
+39% +$3.29M 0.03% 465
2017
Q1
$8.28M Buy
78,433
+1,347
+2% +$131K 0.02% 551
2016
Q4
$6.66M Sell
77,086
-2,170
-3% -$184K 0.02% 600
2016
Q3
$6.77M Sell
79,256
-3,921
-5% -$323K 0.02% 594
2016
Q2
$6.63M Buy
83,177
+53,175
+177% +$3.9M 0.02% 586
2016
Q1
$1.92M Buy
30,002
+3,486
+13% +$191K 0.01% 736
2015
Q4
$1.49M Buy
26,516
+1,310
+5% +$67.4K 0.01% 775
2015
Q3
$1.11M Buy
25,206
+4,521
+22% +$221K ﹤0.01% 807
2015
Q2
$1.14M Buy
20,685
+3,600
+21% +$215K ﹤0.01% 898
2015
Q1
$901K Buy
17,085
+4,209
+33% +$230K ﹤0.01% 925
2014
Q4
$773K Hold
12,876
﹤0.01% 920
2014
Q3
$759K Sell
12,876
-1,048
-8% -$68.1K ﹤0.01% 916
2014
Q2
$994K Sell
13,924
-1,642
-11% -$113K ﹤0.01% 861
2014
Q1
$1.03M Buy
15,566
+1,876
+14% +$121K ﹤0.01% 849
2013
Q4
$870K Buy
+13,690
New +$909K ﹤0.01% 863

Other funds holding ALB

Canada Life's ALB Position: Q1 2026 in Review

Canada Life increased its Albemarle (ALB) stake by 123% in Q1 2026, buying an estimated $18.8M and bringing the position to 199,660 shares worth $35.9M. The position accounts for 0.06% of the portfolio, ranked #251.

Canada Life first reported a position in ALB in Q4 2013 and has held it in 49 quarters since. 983 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Canada Life held 199,660 shares of Albemarle worth $35.9M as of Q1 2026.
  • Canada Life bought 110,231 Albemarle shares in Q1 2026, an estimated $18.8M.
  • Albemarle made up 0.06% of Canada Life's portfolio in Q1 2026, its #251 holding.
  • Canada Life first reported a position in Albemarle in Q4 2013 and has held it in 49 quarters since.
  • 983 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.